During the past decade, Please Contact the Merck KGaA Communication Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 19 clinical trials were completed, i.e. on average, 118.8% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Please Contact the Merck KGaA Communication Center" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Merck Serono Co., Ltd., China" with 2 trials as a collaborator, "Merck B.V., Netherlands" with 1 trials as a collaborator, "Merck Romania SRL, an affiliate of Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Merck Serono Co., Ltd., Japan" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Please Contact the Merck KGaA Communication Center" are "Healthy" (4 trials), "Infertility" (2 trials), "Multiple Myeloma" (2 trials), "Multiple Sclerosis" (2 trials) and "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Please Contact the Merck KGaA Communication Center" in a lesser frequency.

Most popular intervention types in "Please Contact the Merck KGaA Communication Center" are "Drug" (20 trials), "Biological" (5 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Single low dose cyclophosphamide" (3 trials), "Tecemotide (L-BLP25)" (3 trials), "Cysticide" (2 trials) and "GONAL-f®" (2 trials). Other intervention names were less common.

The vast majority of trials in "Please Contact the Merck KGaA Communication Center" are 17 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Please Contact the Merck KGaA Communication Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Please Contact the Merck KGaA Communication Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Please Contact the Merck KGaA Communication Center, 7 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".